NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/11/2025
Back to search
Official data from USPTO
WN PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
WN PHARMACEUTICALS
ST13
US500000078115848Class
5
Filing
78115848
Registration
2906140
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
04/02/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
03/19/2002
Registration date
11/30/2004
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/11/2025
Last transaction
04/02/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
08/19/1996
First use in commerce
09/21/2000
Drawing code
1
Owner type
03
Owner location
Coquitlam, British Columbia, CA
Examiner
BERK,STEVEN R
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
WN Pharmaceuticals Ltd.
WN Pharmaceuticals Ltd.
Representatives
Melissa A. Nowak Christensen O'Connor Johnson Kindness
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Nutritional supplements; dietary supplements; herbal supplements; vitamins; multi-vitamins; mineral supplements; vitamin and mineral supplements; and dietary and herbal supplements; Specialty dietary supplementssalmon oil and methylsulfonlmethane (MSM); dietary food supplementsnamely shark cartilage; vitamin supplements containing apple cider vinegar; dietary supplements containing conjugated linoleic acid (CLA); dietary supplement containing coenzyme; nutritional supplements containing evening primrose oil; nutritional supplements containing flaxseed oil; nutritional supplements containing bilberry; dietary supplements containing lutein formulated for eye health; nutritional supplements containing omega 3-6-9 formulated to supply essential fatty acids of human nutrition; and nutritional supplements containing phosphatidyl serine (PS) to improve human cognitive function
Publications
History of USPTO decisions and trademark events.
30 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/11/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/11/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/11/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
11/04/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/30/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/09/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/09/2019
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
12/17/2014
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/17/2014
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
12/17/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/17/2014
E89R
TEAS SECTION 8 & 9 RECEIVED
11/25/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/25/2014
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/26/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/06/2010
E815
TEAS SECTION 8 & 15 RECEIVED
04/26/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
11/30/2004
PUBO
PUBLISHED FOR OPPOSITION
09/07/2004
NPUB
NOTICE OF PUBLICATION
08/18/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/28/2004
DOCK
ASSIGNED TO EXAMINER
06/01/2004
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/21/2003
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/06/2002
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/06/2002
DOCK
ASSIGNED TO EXAMINER
10/01/2002
GNRT
NON-FINAL ACTION E-MAILED
07/22/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/11/2002
GNRT
NON-FINAL ACTION E-MAILED
07/10/2002
DOCK
ASSIGNED TO EXAMINER
07/09/2002
Continuous trademark protection
Get notified about every new filing that threatens WN PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.